In February, I had the honor of assisting NIH Director Dr. Francis Collins as he announced an unprecedented public health collaboration: the Accelerating Medicines Partnership. As you can read more about in this issue, NIH joined 10 pharmaceutical companies and nonprofit organizations to tackle several public health issues, including type 2 diabetes, in innovative ways.
To make this pilot project a success, we’ll be sharing our unique expertise and resources. NIH brings the power of our worldwide clinical consortiums and data. Industry brings an extensive knowledge of how to identify viable drug targets and bring them to market. More »